ANEBULO PHARMACEUTICALS INC (ANEB) Stock Income Statement
NASDAQ:ANEB • US0345691036
0.36 USD
-0.07 (-16.49%)
At close: Feb 27, 2026
0.382 USD
+0.02 (+6.11%)
After Hours: 2/27/2026, 8:00:00 PM
| TTM (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.10M | 9.22M | 8.31M | 11.78M | 6.83M | |||
| Research and Development | 3.74M | 4.30M | 3.55M | 5.60M | 2.96M | |||
| Selling, General, and Administrative Expenses | 5.36M | 4.92M | 4.76M | 6.18M | 3.87M | |||
| Operating Income | -9.10M | -9.22M | -8.31M | -11.78M | -6.83M | |||
| Interest Income/Expense | 122.40K | -124.10K | 97.80K | 90.00K | 10.00K | |||
| Other Income/Expense | 1.00M | 862.80K | 9.30K | -40.00K | 0.00 | |||
| Income Before Taxes | -7.98M | -8.48M | -8.20M | -11.73M | -6.83M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -7.98M | -8.48M | -8.20M | -11.73M | -6.83M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.19 | -0.25 | -0.32 | -0.47 | -0.29 | |||
| Non GAAP EPS | -0.19 | -0.26 | -0.32 | -0.47 | N/A | |||
| Statistics | ||||||||
All data in USD